Hung Gabriel B K, Cheung H K
Castle Peak Hospital, Tuen Mun, Hong Kong.
Hong Kong Med J. 2008 Feb;14(1):35-9.
To determine the factors associated with high-dose antipsychotic prescribing for psychiatric patients in Hong Kong.
Retrospective cross-sectional study.
Psychiatric in-patients and out-patients in the New Territories West Cluster, Hong Kong.
A total of 1129 in-patients and 7520 out-patients who received antipsychotic medications on the study date.
Demographic and clinical data were compared for patients receiving 'normal' and high dosages of antipsychotic medications.
High dosages were prescribed for 104 (9.2%) of the in-patients and 137 (1.8%) of out-patients. Antipsychotic polypharmacy was the most powerful predictor of high-dose prescribing, with an odds ratio of 8.88 for in-patients and 10.82 for out-patients.
Antipsychotic polypharmacy was the main determinant of high-dose antipsychotic prescribing in this study. Further studies should be conducted to look for other variables contributing to such prescribing in Hong Kong.
确定香港精神病患者高剂量抗精神病药物处方的相关因素。
回顾性横断面研究。
香港新界西联网的精神科住院患者和门诊患者。
在研究日期接受抗精神病药物治疗的1129名住院患者和7520名门诊患者。
比较接受“正常”剂量和高剂量抗精神病药物治疗患者的人口统计学和临床数据。
104名(9.2%)住院患者和137名(1.8%)门诊患者接受了高剂量治疗。抗精神病药物联合使用是高剂量处方最有力的预测因素,住院患者的比值比为8.88,门诊患者为10.82。
抗精神病药物联合使用是本研究中高剂量抗精神病药物处方的主要决定因素。应开展进一步研究以寻找香港地区导致此类处方的其他变量。